Objective: Cardiotrophic growth factors with anti-cell death actions on cardiac myocytes have gained attention for treatment of patients with myocardial infarction. Hepatocyte growth factor (HGF) plays a role in tissue repair and protection from injuries, however, the physiological role of HGF in the myocardium has not been well defined. We asked if HGF would afford to the infarcted myocardium. Methods and results: Mature cardiac myocytes prepared from adult rats expressed barely detectable levels of the c-Met / HGF receptor, however, c-Met receptor expression increased during cultivation, which meant that cardiac myocytes are potential targets of HGF. Addition of hydrogen peroxide remarkably decreased the number of viable mature cardiac myocytes in primary culture, whereas treatment with HGF enhanced survival of the cells subjected to the oxidant stress. Although very low levels of c-Met / HGF receptor and HGF mRNA expression were seen in normal rat hearts, both c-Met / HGF receptor and HGF mRNA levels rapidly increased to much higher levels than normal, when the rats were subjected to myocardial infarction. Immunohistochemical analysis of the c-Met receptor indicated that this receptor was expressed in cardiomyocytes localized in the border regions of the viable myocardium and in non-infarcted regions following myocardial infarction. Conclusion: The c-Met / HGF receptor is induced in cardiomyocytes following myocardial infarction and HGF exhibits protective effect on cardiomyocytes against oxidative stress. Our working hypothesis is that HGF may afford myocardial protection from myocardial infarction.
volvement and application of cardiotrophic growth factors care in compliance with the Principles of Laboratory when analyzing pathogenesis and therapeutics following Animal Care formulated by the National Society for acute myocardial infarction. Particularly, insulin-like
Medical Research and the Guide for the Care and Use of growth factor-I (IGF-I), IGF-II, and basic fibroblast growth
Laboratory Animals prepared by the Institute of Laborafactor (bFGF) were shown to stimulate hypertrophy of tory Animal Resource and published by the National myocytes, to protect against death of myocytes and to Institutes of Health (NIH Publication No. 85-23, revised attenuate ventricular dilation after acute myocardial infarc-1996) . tion [4] [5] [6] .
Myocardial infarction was made as described elsewhere Hepatocyte growth factor (HGF), originally identified [2] . Briefly, Male Wistar rats were anesthetized with and cloned as a potent mitogen for mature hepatocytes sodium pentobarbital (50 mg / kg body weight), and [7] [8] [9] , has mitogenic, motogenic, morphogenic, and antipositive-pressure respiration was applied through an endoapoptotic activities in a wide variety of cells, preferentially tracheal tube. The left thorax was opened via fourth in most epithelial and endothelial cells [10] [11] [12] . One intercostal space, and the left coronary artery was ligated 3 particular importance is the finding that HGF enhances mm distal to its origin by 7-0 polypropylene ligature. For regeneration of organs such as the liver, kidney and lung histopathological analysis, tissues were fixed in 10% (w / v) [11] . Likewise, HGF has angiogenic activity [13] [14] [15] [16] [17] . The formalin, embedded in paraffin and stained with Hematopotent activity of HGF to prevent cell death in distinct xylin and Eosin. types of cells has been documented [18] [19] [20] .
Because of the preferential, but not exclusive, target cell 2.3. Isolation and cultivation of cells specificity of HGF on epithelial and endothelial cells and the relatively low expression of both HGF and c-Met / HGF
The heart was placed on a stainless cannula of Langenreceptor in the normal heart, less attention has been dorff perfusion system for retrograde coronary perfusion directed to pathophysiological roles of HGF in cardiac and perfused through the aorta with modified Krebstissue, except for a restricted number of recent studies Henseleit solution gassed with 95% O / 5% CO at 100 2 2 [21 -25] . In the present study, we found that c-Met is cm H O perfusion pressure at 378C for 10 min. The heart 2 expressed in cardiac myocytes, HGF exhibits cytoprotecwas subsequently perfused with modified Krebs-Henseleit tive actions on mature cardiac myocytes, and both c-Met solution gassed with 95% O / 5% CO containing 0.12% 2 2 receptor and HGF mRNA expression was strongly induced collagenase-D, 0.01% trypsin, 125 PU / ml dispase and following myocardial infarction. The cardiotrophic action 0.11% bovine serum albumin (BSA), and 0.125 mM CaCl 2 of HGF, as mediated by the c-Met receptor deserves our for 20-30 min. Ventricles without valves were removed ongoing attention.
from the cannula, minced, dissociated by pipetting in HEPES Earl's salt (HES). Intact cardiac myocytes were settled by centrifugation at 353g for 3 min. After removal 2. Methods of the supernatant containing cardiac non-myocytes, precipitated cells were resuspended in HES and the centrifu-2.1. Materials gation was repeated three times. The cells were then resuspended in HES containing 4% BSA and centrifuged Human and rat recombinant HGF was purified from the at 253g for 30 sec. The resultant preparation of cardiac culture medium of Chinese hamster ovary cells transfected myocytes contained 70-80% rod-shaped myocytes and the with expression plasmid containing human or rat HGF contamination of non-myocytes was consistently less than cDNA [7] [8] [9] . Purity of HGF exceeded 98% as determined 1%. Cardiac myocytes were suspended in 199 medium by SDS-PAGE and subsequent protein staining. Polycloncontaining 4% fetal bovine serum (FBS) and seeded on a al antibody against rat HGF was prepared from the serum dish coated with 10 mg / ml laminin. After a 1 h culture, the of a rabbit immunized with rat recombinant HGF and IgG medium was changed to serum-free medium and the cells was purified using protein A-Sepharose (Pharmacia were cultured for 24 h. Cardiac endothelial cells were Biotech, Uppsala). Anti-rat HGF IgG (1 mg / ml) completeprepared from the supernatant of the first centrifugation of ly neutralized the biological activities of 1 ng / ml rat HGF.
cardiac cells at 353g (see above). The supernatant was Collagenase-D and dispase were respectively obtained centrifuged at 1203g for 10 min and the precipitated cells from Molecular Biochemicals (Mannheim) and Godo enriched with endothelial cells were resuspended in DulShusei (Tokyo). Human recombinant IGF-I and Wortmanbecco's modified eagle (DME) medium containing 20% nin were respectively obtained from Life Technologies FBS and 50 mg / ml endothelial cell growth supplement. (Rockville, MD) and Sigma (St Louis, MO).
The cells were plated on a culture dish coated with 0.03% type I collagen. Cardiac endothelial cells at the fifth 2.2. Animal treatment and histopathological analysis passage were used. Contamination of non-endothelial cells in the endothelial culture was less than 3% as determined Eight-week-old male Wistar rats were given humane by immunohistochemistry for von Willebrand factor.
Neonatal rat cardiomyocytes were cultured using methsolution was amplified with primers set as follows: 59-TGT ods originally described by elsewhere [26] , but with minor GCG TTC CCC ATC AAA TAT GTC-39 (forward), modification. After the cells had been cultured for 2 days 59-GTC CCA GGC ACA TAT GGT CA-39 (reverse) for in DME medium containing 10% FBS, the cells were mouse c-Met receptor sequence (Gene Bank accession No. cultured in serum-free DME medium for 24 h and used for Y00671); 59-GGT AAG CTT CGG CCT CGT CTC ATA experiments. Purity of the cultured cardiomyocytes ex-GAC AA-39 (forward), 59-TTG AGA TCT GGA GAG ceeds 90%, as determined by immunocytochemical de-AGA ACG AGA GTC AT-39 (reverse) for rat GAPDH tection of a-sarcomeric actin.
(GeneBank accession No. X02231), using GeneAmp PCR System 9600 (Perkin Elmer) with AmpliTaq DNA poly-2.4. Cell survival assay merase (Perkin Elmer). PCR conditions were as follows: 30 cycles, denaturation at 948C for 30 s, followed by Cardiac myocytes were cultured for 24 h in serum-free annealing at 558C for 60 s and extension at 728C for 90 s. condition, then cultured for 12 h in the absence or presence PCR products were subjected to 2% agarose gel electroof HGF. H O (200 mM) was added to cultures of cardiac phoresis and visualized by ethidium bromide staining. To 2 2 myocytes and the cells were further cultured for 2 h. To normalize signals for c-Met, the density value was divided assess viability of the myocytes, rod-shaped and striated by that for GAPDH. The data were presented as arbitrary cells were defined as viable, while round or irregular unit after densitometric analysis with FluorchemE(Alpha shaped cells with loss of striations were considered nonviInnotech Corporation, CA). able [27] . In each sample, at least five fields were observed Real-time quantitative PCR was performed using and 100 cells were randomly counted and evaluated at TaqManE fluorogenic probes for 59 exonuclease assay as each field. In preliminary experiments, the viability of described [29, 30] . Amplification reactions contained a first GTT CCT ACC CCC AAT GTA TCC GT-(TAMRA)39 oratories, Hercules, CA). After blocking, the membrane for rat GAPDH. Reactions were run in the Model 7700 was sequentially incubated with anti-phospho-p44 / p42
Sequence Detector (Perkin Elmer). PCR conditions were MAP kinase (ERK 1 / 2) monoclonal antibody (E10; New as follows: 40 cycles, denaturation at 958C for 15 s, England BioLabs, Beverly, MA) for 1 h, biotinylated followed by annealing and extension at 628C for 60 s. anti-mouse IgG (Vector, Burlingame, CA) for 1 h, horseSamples were matched to a standard curve generated by radish peroxidase-conjugated streptavidin (Amersham, amplifying the serially diluted product in the same PCR. Buckinghamshire) for 1 h and an enhanced chemiluminesStandard curves were obtained in both logarithmic regres- 2 6 cence reagent (Amersham). To detect ERK protein, antision in each product from 10 to 10 copy number (r. ERK 1 antibody (K-23; Santa Cruz Biotechnology, Santa 0.995). To correct for variability in RNA recovery and Cruz, CA) was used. Likewise, to detect total Akt protein efficiency of reverse transcription, GAPDH cDNA was and phosphorylated Akt, anti-Akt ([ 9272; New England amplified and quantitated from each cDNA preparation. Biolabs) and anti-phosphorylated Akt (4E2; New England All samples were done in duplicate. Biolabs) were respectively used for the immunoblotting. For immunohistochemical staining, the cardiac tissue We first analyzed c-Met / HGF receptor expression in was fixed in 10% formalin and embedded in paraffin.
mature cardiac myocytes in primary culture. These Tissue sections were deparaffinized and autoclaved at myocytes, highly purified from the normal rat hearts, were 1208C for 20 min. After washing twice with PBS, tissue cultured for 24 h (Fig. 1A) and subjected to c-Met receptor sections were incubated with 0.3% H O for 5 min at analysis using RT-PCR. When cardiac myocytes and non- 2 2 room temperature followed by PBS containing 3% normal myocytes were freshly isolated from the normal hearts, the goat serum and 2% BSA for 30 min at room temperature.
expression of c-Met receptor mRNA in these types of cells The sections were subsequently incubated with rabbit antiwas weak. However, the expression of c-Met receptor mouse Met IgG (1 mg / m) for 1 h at room temperature, mRNA in cardiac myocytes was significantly increased 24 biotinylated anti-rabbit IgG antibody for 1 h and avidinh after the culture (Fig. 1B) . (Fig. 1C, D) . Western immunoblotting, cardiac myocytes obtained from for 10 min and cell lysates were respectively subjected to neonatal rats were expanded during cultivation and used Western blotting. The basal level of weakly phosfor these experiments. HGF had similar cytoprotective phorylated ERK 1 / 2 was evident in control serum-starved effect on H O -treated neonatal cardiac myocytes in cells, whereas treatment of cardiac myocytes with HGF as 2 2 culture (data not shown). Following serum starvation for well as IGF-I stimulated the phosphorylation of ERK 1 / 2 24 h, cells were stimulated with 10 ng / ml HGF or IGF-I (Fig. 3A) . A specific antibody against HGF inhibited the ERK 1 / 2 phosphorylation induced by HGF but not IGF-I. after 24 h until 2 weeks after treatment. On the other hand, The same amount of cell lysates were simultaneously HGF mRNA levels also increased in a distinct profile to subjected to Western blot by anti-ERK1 antibody to that of c-Met receptor mRNA levels (Fig. 4B ). HGF indicate that the level of total ERK protein were comparmRNA levels in the left ventricle free wall increased from able. On the other hand, treatment with HGF, as well as 6 h after the treatment and increased to 10-fold higher HGF plus Wortmannin, a phosphatidylinositol (PI)-3-kilevels at 72 h. The HGF mRNA levels in the left nase inhibitor, had no significant effect on the phosphorylventricular free wall thereafter decreased, yet was higher ation of Akt in cardiac myocytes (Fig. 3B) .
than that in normal heart 2 weeks after the treatment. HGF mRNA levels in the interventricular septum changed 3.
Induction of HGF and c-Met in the infarcted
relatively in a similar manner to that seen in the left myocardium ventricular free wall: increase was from 12 h after myocardial infarction and reached a peak 72 h after the treatment. To determine the potential involvement of HGF in
These results indicate that both HGF and c-Met / HGF cardiac injury, we analyzed changes in HGF and c-Met receptor mRNA levels increased in the infarcted rat heart. receptor mRNA expression in the heart following myocarTo determine if c-Met receptor mRNA would increase dial infarction induced in rats. RNA was respectively in cardiac myocytes following myocardial infarction, we prepared from the left ventricular free wall, including the analyzed expression of c-Met receptor mRNA in highly infarcted area and interventricular septum, and analyzed purified cardiac myocytes and cardiac cells except for using the real-time quantitative RT-PCR. Although exmyocytes (cardiac non-myocytes), using RT-PCR. Cardiac pression of c-Met receptor mRNA in the intact heart was myocytes and cardiac non-myocytes were isolated from low, this expression increased after myocardial infarction normal and infarcted hearts at 24 h after myocardial (n53 at each time-point) (Fig. 4A) . c-Met receptor mRNA infarction. Although expression of the c-Met receptor was levels in the left ventricular free wall increased from 6 h barely detectable in cardiac myocytes isolated from the after the treatment and continued to increase for up to 7 normal heart, the expression of c-Met receptor mRNA was days. The maximal increase was 40-fold at 7 days after the obvious in cardiac myocytes isolated from the heart 24 h treatment and c-Met receptor mRNA levels decreased after cardiac infarction (Fig. 4C) . Likewise, c-Met receptor thereafter. The c-Met receptor mRNA levels in the interexpression in cardiac non-myocytes also increased after the ventricular septum also increased from 6 h after the cardiac infarction. Therefore, cardiac myocytes become treatment and a maximally increased expression continued target cells of HGF, in response to myocardial infarction. (Fig. 5A, D) , whereas most of these cells in the infarcted region were negative for immunohistochemical detection To confirm the induction of c-Met receptor expression in of the c-Met receptor. c-Met receptor expression in viable cardiomyocytes, localization of c-Met receptor protein in region, as well as the lack of c-Met receptor expression in the rat heart was analyzed immunohistochemically (Fig. infarcted region, were more clearly seen in immuno-5). Consistent with the low level expression of c-Met histochemical analysis in border regions. Fig. 5A and Fig.  receptor mRNA in normal heart, c-Met receptor expression 5C, respectively, show c-Met receptor expression and in the normal heart was faintly detectable, using immunoHematoxylin and Eosin-stained tissue in border regions histochemical analysis (not shown). On the other hand, between the infarcted and non-infarcted regions, in serial c-Met receptor-positive cells were evident in the heart 24 h sections. Hematoxylin and eosin staining showed cells in after the induced myocardial infarction. Both cardiac the upper half were characterized by disappearance of the myocytes and vascular endothelial cells in border regions striated pattern in myocytes, nuclear aggregation and and also in non-infarcted distant regions were positive for acidic staining of cytoplasm, indicating that these cells c-Met receptor expression 24 h after myocardial infarction were not viable after myocardial infarction (Fig. 5C ). Cells located in the lower half were c-Met-positive, whereas gered by HGF and IGF-I are mediated receptor tyrosine those in the upper half were c-Met negative (Fig. 5A) .
Localization of c-Met receptor in myocardium
kinases. In this context, it was noted that Bag-1, a partner Cells in infarcted regions might not have been viable, of Bcl-2 / Bcl-xL [36] , is specifically associated with the hence incapable of protein synthesis. Immunohistochemic-Met / HGF receptor and expression of Bag-1 promotes cal staining, using normal IgG, showed no staining (Fig. the cell survival activity of HGF [18] . Possible in-5B, E). These results suggested that mature cardiac volvement of Bag-1 and the Bcl-2 / Bcl-xL-related pathway myocytes as well as cardiac vascular endothelial cells in HGF-dependent myocardial protection remains to be might be target cells of HGF, when myocardial was defined. ischemically injured. A previous report [22] showed that Previous studies focused on expression of c-Met recardiac endothelial cells expressed the c-Met receptor ceptor in cardiac endothelial cells after acute myocardial while cardiac myocytes did not express the receptor both infarction and biological effects of HGF on these cells. in normal hearts and hearts subjected to myocardial Coronary endothelial cells express c-Met receptor and infarction. As Ono et al. used an anti-human c-Met c-Met mRNA expression in the heart increases following antibody, such may explain the discrepancy.
cardiac ischemia-reperfusion injury [22] , and HGF exhibits mitogenic effect on rat coronary endothelial cells [14] . A recent study demonstrated potential therapeutic angiogen-4. Discussion esis induced by transfection and expression of HGF gene delivered to the infarcted myocardium [17] . These results Despite a number of studies on 'trophic' actions of HGF revealed that HGF has a physiological role as well as for regeneration and / or maintenance of organs, including therapeutic value in cases of myocardial infarction, based the liver, kidney, lung, stomach, and cerebrum, less on angiogenic and angioprotective actions of HGF. Toattention has been directed to the physiological role of gether with our present finding, biological actions of HGF HGF in the heart. We reported that HGF gene transfection for both cardiac myocytes and coronary endothelial cells into the myocardium attenuated ischemia-reperfusion inmeans that HGF may afford myocardial protection. jury, although related mechanisms remained to be deMyocardial infarction often causes ventricular dilatation termined [23] . In the present study, we found that although characterized by a diminished cardiac performance, poor expression of both HGF and c-Met receptor were low in recovery of function, and increased mortality. The underlythe normal myocardium, mature cardiac myocytes do ing mechanism responsible for cardiac dilatation has been express the c-Met receptor in response to myocardial linked to myocyte cell death in the surviving regions [3] . infarction and during cultivation, and that HGF had direct Thus strategies for the treatment of myocardial infarction cytoprotective effects on mature cardiac myocytes. Alhave focused on protection against myocyte death and the though a previous report showed up-regulation of c-Met restoration of blood flow. Polypeptide growth factors with receptor expression in cardiac endothelial cells following cardiotrophic and / or angiogenic activities have been tested cardiac ischemia-reperfusion injury [22] , this is the first for their therapeutic effects in case of myocardial infarcreport to show the induction of the c-Met receptor in tion. Administration of IGF-I or IGF-II to laboratory mature cardiac myocytes following myocardial infarction animals improved myocardial function after induced and cytoprotective actions of HGF in the cells. myocardial infarction [5, 37] and transgenic expression of Other workers reported that protective effects of cardiot-IGF-I protected from myocyte death and attenuated venrophic factors such as IGF-I and leukemia inhibitory factor tricular dilatation [4] . We propose that HGF may play the involve ERK activation [31, 33] . Inhibition of ERK phosrole of a physiological cardiotrophic factor, as well as an phorylation by a specific inhibitor resulted in increased cell angiogenic factor, in maintaining of cardiac function. Our death in cardiomyocytes and ischemia-reperfusion injury in latest report showed that HGF reduced infarct area by isolated rat hearts [34, 35] . In addition to the ERK-related suppressing cell death of cardiomyocytes in rats with pathway, stimulation of Akt downstream of PI3-kinase is ischemia-reperfusion injury, thereby suggesting possible involved in protection of cardiomyocytes by IGF-I [32].
therapeutic advantages for treating subjects with myocarSince HGF shares similar protective effect with IGF-I, we dial infarction [38] . analyzed the phosphorylation state of ERK1 / 2 and Akt by these factors. Consistent with previous reports, IGF-1 stimulated both ERK1 / 2 and Akt phosphorylation in our
